March 01, 2022
Video
Closing out his discussion on advanced endometrial carcinoma, Michael Birrer, MD, PhD, shares his hope for future treatment advances.
March 01, 2022
Video
Expert perspectives on Study 309/KEYNOTE-775, which combined pembrolizumab with lenvatinib in patients with advanced endometrial carcinoma.
March 01, 2022
Video
Insight on the optimal sequencing of therapy in patients with advanced endometrial cancer based on MMR and MSI status.
March 01, 2022
Video
Michael Birrer, MD, PhD, considers the role of pembrolizumab in advanced endometrial cancer given results from KEYNOTE-158.
March 01, 2022
Video
A broad look at the systemic and targeted therapies available for patients diagnosed with advanced endometrial carcinoma.
March 01, 2022
Video
Focused discussion on risk factors that may drive endometrial cancer followed by advice on optimal diagnostic work-up.